HFA Premium Access

Phase 1b evaluation of safety and activity of JK07 in heart failure with reduced ejection fraction

Congress Presentation

About the speaker

Professor Wai Hong Wilson Tang

Cleveland Clinic, Cleveland (United States of America)
4 presentations
1 follower

5 more presentations in this session

Remote Hemodynamic Monitoring of Pulmonary Artery Pressures in Patients with Chronic Heart Failure (MONITOR-HF): A randomized controlled clinical trial

Speaker: Associate Professor J. Brugts (Rotterdam, NL)


TRACER-HF: Trientine-HCL for treatment of heart failure and reduced ejection fraction

Speaker: Professor J. Januzzi (Boston, US)


REDWOOD-HCM-Cohort 4: Aficamten in non-obstructive HCM

Speaker: Doctor A. Masri (Portland, US)


Primary results of the Phase Ib proof-of-concept study of NI006, a recombinant human antibody to deplete amyloid deposits in ATTR-cardiomyopathy

Speaker: Doctor P. Garcia-Pavia (Majadahonda, ES)


Patisiran treatment for ATTR cardiac amyloidosis: 18-month results of the phase 3 APOLLO-B study

Speaker: Professor M. Fontana (London, GB)


Access the full session

Late breaking clinical trials: chronic HF and cardiomyopathies

Speakers: Professor W. Tang, Associate Professor J. Brugts, Professor J. Januzzi, Doctor A. Masri, Doctor P. Garcia-Pavia...

About the event


Heart Failure 2023

20 May - 23 May 2023

Sessions Presentations

ESC 365 is supported by